v3.25.2
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Total National Health Investors, Inc. Stockholders’ Equity
Common Stock
Capital in Excess of Par Value
Retained Earnings
Cumulative Dividends
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2023     43,409,841        
Beginning balance at Dec. 31, 2023 $ 1,264,391 $ 1,253,952 $ 434 $ 1,603,757 $ 2,466,844 $ (2,817,083) $ 10,439
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Distributions declared to noncontrolling interests, excluding attributable to redeemable noncontrolling interest (205)           (205)
Net income, excluding loss attributable to redeemable noncontrolling interest 30,882 30,947     30,947   (65)
Share-based compensation expense 2,155 2,155   2,155      
Grants of restricted stock awards (in shares)     15,000        
Dividends declared, per common share (39,082) (39,082)       (39,082)  
Activity for the end of the period (in shares)     15,000        
Activity for the end of the period (6,250) (5,980) $ 0 2,155 30,947 (39,082) (270)
Ending balance (in shares) at Mar. 31, 2024     43,424,841        
Ending balance at Mar. 31, 2024 1,258,141 1,247,972 $ 434 1,605,912 2,497,791 (2,856,165) 10,169
Beginning balance (in shares) at Dec. 31, 2023     43,409,841        
Beginning balance at Dec. 31, 2023 $ 1,264,391 1,253,952 $ 434 1,603,757 2,466,844 (2,817,083) 10,439
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Shares issued on stock options exercised (in shares) 122,174            
Ending balance (in shares) at Jun. 30, 2024     43,442,849        
Ending balance at Jun. 30, 2024 $ 1,254,303 1,244,417 $ 434 1,606,199 2,533,047 (2,895,263) 9,886
Beginning balance (in shares) at Mar. 31, 2024     43,424,841        
Beginning balance at Mar. 31, 2024 1,258,141 1,247,972 $ 434 1,605,912 2,497,791 (2,856,165) 10,169
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Noncontrolling interest capital contribution 70           70
Distributions declared to noncontrolling interests, excluding attributable to redeemable noncontrolling interest (303)           (303)
Net income, excluding loss attributable to redeemable noncontrolling interest 35,206 35,256     35,256   (50)
Share-based compensation expense 687 687   687      
Shares issued on stock options exercised (in shares)     18,238        
Taxes related to net settlement of equity awards (in shares)     (230)        
Taxes related to net settlement of equity awards (400) (400)   (400)      
Dividends declared, per common share (39,098) (39,098)       (39,098)  
Activity for the end of the period (in shares)     18,008        
Activity for the end of the period (3,838) (3,555) $ 0 287 35,256 (39,098) (283)
Ending balance (in shares) at Jun. 30, 2024     43,442,849        
Ending balance at Jun. 30, 2024 $ 1,254,303 1,244,417 $ 434 1,606,199 2,533,047 (2,895,263) 9,886
Beginning balance (in shares) at Dec. 31, 2024 45,687,942   45,687,942        
Beginning balance at Dec. 31, 2024 $ 1,375,387 1,366,475 $ 457 1,736,831 2,604,829 (2,975,642) 8,912
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Distributions declared to noncontrolling interests, excluding attributable to redeemable noncontrolling interest (236)           (236)
Net income, excluding loss attributable to redeemable noncontrolling interest 34,060 34,165     34,165   (105)
Issuance of common shares, net (in shares)     960,000        
Issuance of common shares, net 65,483 65,483 $ 10 65,473      
Equity issuance costs (47) (47)   (47)      
Share-based compensation expense 2,558 2,558   2,558      
Grants of restricted stock awards (in shares)     29,500        
Shares issued on stock options exercised (in shares)     16,763        
Taxes related to net settlement of equity awards (in shares)     (534)        
Taxes related to net settlement of equity awards (136) (136)   (136)      
Dividends declared, per common share (42,024) (42,024)       (42,024)  
Activity for the end of the period (in shares)     1,005,729        
Activity for the end of the period 59,658 59,999 $ 10 67,848 34,165 (42,024) (341)
Ending balance (in shares) at Mar. 31, 2025     46,693,671        
Ending balance at Mar. 31, 2025 $ 1,435,045 1,426,474 $ 467 1,804,679 2,638,994 (3,017,666) 8,571
Beginning balance (in shares) at Dec. 31, 2024 45,687,942   45,687,942        
Beginning balance at Dec. 31, 2024 $ 1,375,387 1,366,475 $ 457 1,736,831 2,604,829 (2,975,642) 8,912
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Shares issued on stock options exercised (in shares) 106,817            
Ending balance (in shares) at Jun. 30, 2025 45,687,942   47,473,160        
Ending balance at Jun. 30, 2025 $ 1,487,973 1,479,645 $ 475 1,863,582 2,675,981 (3,060,393) 8,328
Beginning balance (in shares) at Mar. 31, 2025     46,693,671        
Beginning balance at Mar. 31, 2025 1,435,045 1,426,474 $ 467 1,804,679 2,638,994 (3,017,666) 8,571
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Noncontrolling interest capital contribution 56           56
Distributions declared to noncontrolling interests, excluding attributable to redeemable noncontrolling interest (194)           (194)
Net income, excluding loss attributable to redeemable noncontrolling interest 36,882 36,987     36,987   (105)
Issuance of common shares, net (in shares)     776,348        
Issuance of common shares, net 58,001 58,001 $ 8 57,993      
Equity issuance costs (106) (106)   (106)      
Share-based compensation expense 1,071 1,071   1,071      
Shares issued on stock options exercised (in shares)     3,794        
Taxes related to net settlement of equity awards (in shares)     (653)        
Taxes related to net settlement of equity awards (55) (55)   (55)      
Dividends declared, per common share (42,727) (42,727)       (42,727)  
Activity for the end of the period (in shares)     779,489        
Activity for the end of the period $ 52,928 53,171 $ 8 58,903 36,987 (42,727) (243)
Ending balance (in shares) at Jun. 30, 2025 45,687,942   47,473,160        
Ending balance at Jun. 30, 2025 $ 1,487,973 $ 1,479,645 $ 475 $ 1,863,582 $ 2,675,981 $ (3,060,393) $ 8,328